financetom
Business
financetom
/
Business
/
Hearing Solutions to utilise ₹50 crore fundraise for nationwide expansion, says managing director
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Hearing Solutions to utilise ₹50 crore fundraise for nationwide expansion, says managing director
Nov 20, 2023 11:22 AM

Hearing Solutions, the company behind the Hearzap hearing care chain, has successfully secured ₹50 crore in funding from the healthcare and life sciences-focused private equity fund of 360 One Asset Management.

S Raja, Managing Director of Hearing Solutions, expressed the company's strategic plans for the newly acquired funds, stating, "We plan to utilise these funds for spreading awareness through digital platforms and increase our footprint across the country."

Hearzap specialises in providing hearing care solutions and has developed a digital suite of audiology applications for remote diagnosis and virtual shopping of hearing care devices.

Raja highlighted that the company aims to reach revenue of ₹100 crore by next year. Last year the company did revenue of ₹60 crore and is looking to hit revenue of ₹75 crore in the current year.

The Hyderabad-headquartered startup also aims to increase its store count from 90 to 150 by the end of the next calendar year.

The company also has plans to launch partner-owned, company-operated stores to engage with a broader audience, especially in Tier II and Tier III cities.

Additionally, Param Gandhi, Co-Founder of Fibmold, and Reihem Roy, Partner at Omnivore, share insights into the future plans of Fibmold, a startup founded in 2022 that focuses on sustainable packaging.

Fibmold recently raised $10 million and specialises in developing eco-friendly molded fiber packaging products, providing alternatives to single-use plastic in various industries.

According to Gandhi, a significant portion of the raised capital will be dedicated to establishing a pilot manufacturing plant. Moreover, a certain amount will be invested in research and development initiatives and team building.

Watch the accompanying video for the entire discussion

(Edited by : Ajay Vaishnav)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Keek Social Up 21% as it Launches Social Wallet and User Monetization Services
Keek Social Up 21% as it Launches Social Wallet and User Monetization Services
Oct 21, 2025
01:19 PM EDT, 10/21/2025 (MT Newswires) -- Keek Social (TSXV: KEEK) shares were last seen up 21% on Tuesday after its Phase 1 launch of its Social Wallet and User monetization services. The company said its Social Wallet is an e-wallet that allows users to transact in multiple currencies and will act as a repository for Keek users to collect...
OpenAI launches AI browser Atlas
OpenAI launches AI browser Atlas
Oct 21, 2025
Oct 21 (Reuters) - OpenAI on Tuesday launched ChatGPT Atlas, an AI-powered web browser built around its chatbot. The browser is now available globally on Apple's ( AAPL ) macOS. It will soon be made available on Windows, iOS and Android. Reuters had in July reported the AI startup, backed by Microsoft ( MSFT ), was close to releasing an...
Early consumer earnings make the wealth effect clear
Early consumer earnings make the wealth effect clear
Oct 21, 2025
(Reuters) -Prominent consumer-facing companies Coke, 3M ( MMM ), General Motors ( GM ) and Philip Morris ( PM ) all flagged consumer resilience in their earnings reports on Tuesday - depending on the consumer. Case in point: industrial conglomerate 3M ( MMM ) raised its profit expectations for 2025, while also flagging weakness in the consumer and housing sectors...
DRI Healthcare Trust Price Target Edges up to $20 at Stifel Canada
DRI Healthcare Trust Price Target Edges up to $20 at Stifel Canada
Oct 21, 2025
01:18 PM EDT, 10/21/2025 (MT Newswires) -- Stifel Canada has raised its one year price target on DRI Healthcare Trust (DHT-UN.TO) by $1, to $20, and reiterated its Buy rating, after the company announced Monday a Synthetic Royalty transaction for interest in Veligrotug by Viridian Therapeutics and the treatment of Thyroid Eye Disease (TED). The transaction is the second pre-FDA...
Copyright 2023-2026 - www.financetom.com All Rights Reserved